Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Healthletic BPC-157 distinguishes itself from injectable peptides by offering convenience, lab-tested purity, and a non-invasive alternative for those seeking systemic repair support
Temperature requirements Refrigerate immediately after reconstitution
IGF-1 is the primary mediator of GHs downstream effects in tissue, muscle, bone, and skin
Maquart, Pickart, and colleagues established this in fibroblast culture in 1988 ( FEBS Letters ) and confirmed it in vivo in rat wound models in 1993 ( Journal of Clinical Investigation ) 5 6
In April 2026, the FDA quietly removed about a dozen of these gray-market peptides, BPC-157 among them, from its list of bulk substances that raise significant safety concerns
.jpg)